Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. taviguide

TAVIguide

ICT platform to reduce mortality rates for Transcatheter Aortic Valve Implantation (TAVI) by pre-operative risk management

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 TAVIguide project word cloud

Explore the words cloud of the TAVIguide project. It provides you a very rough idea of what is the project "TAVIguide" about.

2014    distinctly    25    medical    grow    taviguide    verified    centres    blood    patients    care    implantation    trade    revenue    healthcare    preparation    thereby    fda    risk    correctly    3d    4x    software    marketing    found    digital    7b    ageing    manufacturers    mitral    ict    mitigate    provides    6    fee    operative    flow    prospective    elaborated    global    selling    beneficial    prepare    device    share    license    feasibility    tavi    competitive    give    fast    offerings    5    enabled    platform    valve    commercialization    analysed    additional    heart    service    personalized    model    solution    procedure    entry    4b    sustainable    validation    offers    rates    2025    plus    society    lt    quality    physicians    thanks    population    business    tackle    surgeons    simulation    2021    aortic    pillar    proposition    reducing    therapy    market    approval    plan    size    vii    health    mortality    optimize    complications    disease    groundbreaking    innovative    economic    stakeholders    accurate    disruptive    groups    positive    patient    huge    our    benefits    12   

Project "TAVIguide" data sheet

The following table provides information about the project.

Coordinator		 FEOPS NV 

Organization address
address: TECHNOLOGIEPARK ZWIJNAARDE 122
city: GENT
postcode: 9052
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Belgium [BE]
 Project website http://www.feops.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2016-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FEOPS NV BE (GENT) coordinator 50˙000.00

Map

 Project objective

Our market disruptive TAVIguide™ ICT solution (a Software-as-a-Service platform) will be distinctly beneficial for the global healthcare system with a positive impact on two main groups: a favourable economic impact for medical centres and physicians and an improved quality of care and experience for patients. Our ICT platform addresses an innovative digital health ICT concept and service and will help to tackle the society's challenge of growing needs for sustainable and personalized healthcare (ICT Pillar VII “ICT-enabled benefits for EU society”). It provides surgeons with a groundbreaking ICT solution thanks to beyond State-of-the-Art patient-specific 3D heart modelling and blood flow simulation for pre-operative analysis and preparation of aortic valve implantation. These unique features, not found in competitive offerings, allow to correctly assess and mitigate the complications risk, thereby reducing mortality rates across all TAVI patients from up to 25% after 1 year to <5%. Our TAVIguide™ platform offers a huge potential to device manufacturers who can use the accurate modelling and simulation features to further optimize their TAVI devices and prepare the way for patient-specific valve design. Our business concept is based on a software license revenue model plus fee per case. FDA approval and validation in a prospective patient study during Phase 2 will give us a unique selling proposition for different TAVI stakeholders. Commercialization of TAVIguide™ is planned on a global scale (EU and US). Due to the growing medical importance of the TAVI procedure and an ageing population, the target TAVI market is expected to grow from 1.4B€ (2014) to 4.7B€ (2025). We aim for a 12.6% share by 2021. An additional market entry for mitral valve disease therapy, 4x the TAVI market size, will be analysed. The elaborated business plan and verified technical and marketing feasibility for additional medical applications will prepare our solution for fast market uptake.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TAVIGUIDE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TAVIGUIDE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

REALM (2015)

A disruptive method to free physicians from Hospital Information Systems by generating fault free patient diagnostic documents in real-time using natural language

Read More  

DIGISTONE P1 (2014)

Production and Market entry financing of Digital Concrete Screen for Outdoor Digital Signage application

Read More  

HYBCOPTER (2016)

Hybrid multi copter with 6 times more flight time.

Read More